GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.87B
KLGCX
Price
$38.97
Change
-$0.10 (-0.26%)
Updated
May 9 closing price
Net Assets
862.77M
Ad is loading...

GAFFX vs KLGCX

Header iconGAFFX vs KLGCX Comparison
Open Charts GAFFX vs KLGCXBanner chart's image
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.87B
NYLI WMC Growth
Price$38.97
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets862.77M
GAFFX vs KLGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. KLGCX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and KLGCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 286B vs. KLGCX (863M). GAFFX pays higher dividends than KLGCX: GAFFX (0.70) vs KLGCX (0.00). GAFFX was incepted earlier than KLGCX: GAFFX (8 years) vs KLGCX (12 years). KLGCX (2.16) is less costly to investors than GAFFX (0.30). KLGCX is a more actively managed with annual turnover of: 69.00 vs. GAFFX (25.00). KLGCX has a lower initial minimum investment than GAFFX: KLGCX (2500) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 3.51 vs. KLGCX (1.67). GAFFX return over 5 years is better than : 46.03 vs. KLGCX (16.47).
GAFFXKLGCXGAFFX / KLGCX
Total Expense Ratio0.302.0814%
Annual Report Gross Expense Ratio0.302.1614%
Fund Existence8 years12 years-
Gain YTD-2.444-4.78951%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets286B863M33,140%
Annual Yield % from dividends0.700.00-
Returns for 1 year3.511.67210%
Returns for 3 years34.0841.9281%
Returns for 5 years46.0316.47280%
Returns for 10 yearsN/A22.28-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics